Dual‐specificity MAP kinase phosphatases (MKPs)

Abstract

Dual‐specificity MAP kinase phosphatases (MKPs) provide a complex negative regulatory network that acts to shape the duration, magnitude and spatiotemporal profile of MAP kinase activities in response to both physiological and pathological stimuli. Individual MKPs may exhibit either exquisite specificity towards a single mitogen‐activated protein kinase (MAPK) isoform or be able to regulate multiple MAPK pathways in a single cell or tissue. They can act as negative feedback regulators of MAPK activity, but can also provide mechanisms of crosstalk between distinct MAPK pathways and between MAPK signalling and other intracellular signalling modules. In this review, we explore the current state of knowledge with respect to the regulation of MKP expression levels and activities, the mechanisms by which individual MKPs recognize and interact with different MAPK isoforms and their role in the spatiotemporal regulation of MAPK signalling.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 134

1. 1.

   Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev. 1999;79:143-180.

   Not in our library10.1152/physrev.1999.79.1.143

2. 2.

   Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene. 2007;26:3100-3112.

   Not in our library10.1038/sj.onc.1210392

3. 3.

   Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 2004;23:2838-2849.

   Not in our library10.1038/sj.onc.1207556

4. 4.

   Turjanski AG, Vaque JP, Gutkind JS. MAP kinases and the control of nuclear events. Oncogene. 2007;26:3240-3253.

   Not in our library10.1038/sj.onc.1210415

5. 5.

   Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev. 2012;92:689-737.

   Not in our library10.1152/physrev.00028.2011

6. 6.

   Rincon M, Davis RJ. Regulation of the immune response by stress-activated protein kinases. Immunol Rev. 2009;228:212-224.

   Not in our library10.1111/j.1600-065x.2008.00744.x

7. 7.

   Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene. 2007;26:3279-3290.

   Not in our library10.1038/sj.onc.1210421

8. 8.

   Lawrence MC, Jivan A, Shao C, Duan L, Goad D, Zaganjor E, Osborne J, McGlynn K, Stippec S, Earnest S, et al. The roles of MAPKs in disease. Cell Res. 2008;18:436-442.

   Not in our library10.1038/cr.2008.37

9. 9.

   Marshall CJ. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev. 1994;4:82-89.

   Not in our library10.1016/0959-437x(94)90095-7

10. 10.

    Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol. 1999;71:479-500.

    Not in our library10.1016/s0079-6107(98)00056-x

11. 11.

    Coulombe P, Meloche S. Atypical mitogen-activated protein kinases: structure, regulation and functions. Biochim Biophys Acta. 2007;1773:1376-1387.

    Not in our library10.1016/j.bbamcr.2006.11.001

12. 12.

    Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995;80:179-185.

    Not in our library10.1016/0092-8674(95)90401-8

13. 13.

    Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol. 2000;12:186-192.

    Not in our library10.1016/s0955-0674(99)00075-7

14. 14.

    Patterson KI, Brummer T, O’Brien PM, Daly RJ. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J. 2009;418:475-489.

    Not in our library10.1042/bj20082234

15. 15.

    Dickinson RJ, Keyse SM. Diverse physiological functions for dual-specificity MAP kinase phosphatases. J Cell Sci. 2006;119:4607-4615.

    Not in our library10.1242/jcs.03266

16. 16.

    Owens DM, Keyse SM. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene. 2007;26:3203-3213.

    Not in our library10.1038/sj.onc.1210412

17. 17.

    Theodosiou A, Ashworth A. MAP kinase phosphatases. Genome Biol. 2002;3:3009.

    Not in our library10.1186/gb-2002-3-7-reviews3009

18. 18.

    Camps M, Nichols A, Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 2000;14:6-16.

    Not in our library

19. 19.

    Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J. 1996;15:3621-3632.

    Not in our library

20. 20.

    Muda M, Theodosiou A, Rodrigues N, Boschert U, Camps M, Gillieron C, Davies K, Ashworth A, Arkinstall S. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem. 1996;271:27205-27208.

    Not in our library10.1074/jbc.271.44.27205

21. 21.

    Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 1995;270:7420-7426.

    Not in our library10.1074/jbc.270.13.7420

22. 22.

    Slack DN, Seternes OM, Gabrielsen M, Keyse SM. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. J Biol Chem. 2001;276:16491-16500.

    Not in our library10.1074/jbc.m010966200

23. 23.

    Nichols A, Camps M, Gillieron C, Chabert C, Brunet A, Wilsbacher J, Cobb M, Pouyssegur J, Shaw JP, Arkinstall S. Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3. J Biol Chem. 2000;275:24613-24621.

    Not in our library10.1074/jbc.m001515200

24. 24.

    Tanoue T, Adachi M, Moriguchi T, Nishida E. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol. 2000;2:110-116.

    Not in our library10.1038/35000065

25. 25.

    Tanoue T, Yamamoto T, Nishida E. Modular structure of a docking surface on MAPK phosphatases. J Biol Chem. 2002;277:22942-22949.

    Not in our library10.1074/jbc.m202096200

26. 26.

    Tanoue T, Maeda R, Adachi M, Nishida E. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO J. 2001;20:466-479.

    Not in our library10.1093/emboj/20.3.466

27. 27.

    Chang CI, Xu BE, Akella R, Cobb MH, Goldsmith EJ. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol Cell. 2002;9:1241-1249.

    Not in our library10.1016/s1097-2765(02)00525-7

28. 28.

    Liu S, Sun JP, Zhou B, Zhang ZY. Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. Proc Natl Acad Sci USA. 2006;103:5326-5331.

    Not in our library10.1073/pnas.0510506103

29. 29.

    Bott CM, Thorneycroft SG, Marshall CJ. The sevenmaker gain-of-function mutation in p42 MAP kinase leads to enhanced signalling and reduced sensitivity to dual specificity phosphatase action. FEBS Lett. 1994;352:201-205.

    Not in our library10.1016/0014-5793(94)00958-9

30. 30.

    Zhang YY, Wu JW, Wang ZX. A distinct interaction mode revealed by the crystal structure of the kinase p38alpha with the MAPK binding domain of the phosphatase MKP5. Sci Signal. 2011;4:ra88.

    Not in our library10.1126/scisignal.2002241

31. 31.

    Chen P, Hutter D, Yang X, Gorospe M, Davis RJ, Liu Y. Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically. J Biol Chem. 2001;276:29440-29449.

    Not in our library10.1074/jbc.m103463200

32. 32.

    Camps M, Nichols A, Gillieron C, Antonsson B, Muda M, Chabert C, Boschert U, Arkinstall S. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science. 1998;280:1262-1265.

    Not in our library10.1126/science.280.5367.1262

33. 33.

    Stewart AE, Dowd S, Keyse SM, McDonald NQ. Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation. Nat Struct Biol. 1999;6:174-181.

    Not in our library10.1038/5861

34. 34.

    Rigas JD, Hoff RH, Rice AE, Hengge AC, Denu JM. Transition state analysis and requirement of Asp-262 general acid/base catalyst for full activation of dual-specificity phosphatase MKP3 by extracellular regulated kinase. Biochemistry. 2001;40:4398-4406.

    Not in our library10.1021/bi002951v

35. 35.

    Zhou B, Zhang ZY. Mechanism of mitogen-activated protein kinase phosphatase-3 activation by ERK2. J Biol Chem. 1999;274:35526-35534.

    Not in our library10.1074/jbc.274.50.35526

36. 36.

    Zhang Q, Muller M, Chen CH, Zeng L, Farooq A, Zhou MM. New insights into the catalytic activation of the MAPK phosphatase PAC-1 induced by its substrate MAPK ERK2 binding. J Mol Biol. 2005;354:777-788.

    Not in our library10.1016/j.jmb.2005.10.006

37. 37.

    Mandl M, Slack DN, Keyse SM. Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5. Mol Cell Biol. 2005;25:1830-1845.

    Not in our library10.1128/mcb.25.5.1830-1845.2005

38. 38.

    Tanoue T, Moriguchi T, Nishida E. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J Biol Chem. 1999;274:19949-19956.

    Not in our library10.1074/jbc.274.28.19949

39. 39.

    Jeong DG, Yoon TS, Kim JH, Shim MY, Jung SK, Son JH, Ryu SE, Kim SJ. Crystal structure of the catalytic domain of human MAP kinase phosphatase 5: structural insight into constitutively active phosphatase. J Mol Biol. 2006;360:946-955.

    Not in our library10.1016/j.jmb.2006.05.059

40. 40.

    Jeong DG, Cho YH, Yoon TS, Kim JH, Ryu SE, Kim SJ. Crystal structure of the catalytic domain of human DUSP5, a dual specificity MAP kinase protein phosphatase. Proteins. 2007;66:253-258.

    Not in our library10.1002/prot.21224

Cited by papers we hold 19

• FOXO transcription factor family in cancer and metastasis · 2020
  No notice
• Functions of p38 MAP Kinases in the Central Nervous System · 2020
  No notice
• Corticosteroids inhibit Mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition · 2019
  Not checked
• Targeting Oncogenic BRAF: Past, Present, and Future · 2019
  No notice
• Regulation of Dual-Specificity Phosphatase (DUSP) Ubiquitination and Protein Stability · 2019
  No notice
• Dual-Specificity Phosphatases in Immunity and Infection: An Update · 2019
  No notice
• Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology · 2018
  No notice
• ETS-targeted therapy: can it substitute for MEK inhibitors? · 2017
  Not checked
• Control of cell death and mitochondrial fission by ERK 1/2 MAP kinase signalling · 2017
  No notice
• Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer · 2017
  No notice
• The RNA-binding protein TTP is a global post-transcriptional regulator of feedback control in inflammation · 2016
  No notice
• Let-7a gene knockdown protects against cerebral ischemia/reperfusion injury · 2016
  Not checked
• Early ERK1/2 activation promotes DRP1-dependent mitochondrial fission necessary for cell reprogramming · 2016
  No notice
• Inhibition of ROS and upregulation of inflammatory cytokines by FoxO3a promotes survival against Salmonella typhimurium · 2016
  Not checked
• The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs) · 2016
  No notice
• Negative feedback regulation of the ERK1/2 MAPK pathway · 2016
  No notice
• Zinc-finger nuclease knockout of dual-specificity protein phosphatase-5 enhances the myogenic response and autoregulation of cerebral blood flow in FHH.1BN rats. · 2014
  Not checked
• The Concise Guide to PHARMACOLOGY 2013/14: Enzymes · 2013
  No notice
• Crosstalk and Signaling Switches in Mitogen-Activated Protein Kinase Cascades · 2012
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.